MGP Ingredients (MGPI) Q4 2025 earnings summary

Executive summary

• Full-year 2025 results exceeded the top end of guidance despite a challenging spirits industry backdrop and deliberate repositioning efforts.

• Strategic initiatives and organizational changes were implemented to drive long-term growth, with operational improvements and cost discipline partially offsetting headwinds in brown goods.

• A significant non-cash impairment in the Branded Spirits segment drove reported net losses.

Financial highlights

• Full-year 2025 consolidated sales declined 24% year-over-year to $536.4 million; Q4 sales down 23% to $138.3 million.

• Adjusted EBITDA for 2025 fell 41% to $116.0 million; adjusted basic EPS was $2.85, down 49%; Q4 adjusted EPS was $0.63, down 60%.

• Net income for 2025 was a loss of $107.8 million, primarily due to a $152.6 million non-cash impairment.

• Cash flow from operations reached a record $121.5 million, up 19% year-over-year.

• Capital expenditures declined over 50% to $31.9 million.

Outlook and guidance

• 2026 net sales expected at $480–$500 million; adjusted EBITDA $90–$98 million; adjusted EPS $1.50–$1.80; effective tax rate around 27%.

• Branded Spirits sales to decline mid-single digits; gross margin to improve modestly.

• Distilling Solutions sales expected down 35%, gross profit down 40% year-over-year.

• Ingredient Solutions sales expected at $140–$150 million, with gross margin in the mid to high teens.

• CapEx for 2026 projected at $20 million; Penelope earnout payment of $111 million in Q2.

• Net debt leverage to peak at 3.75x in Q2 2026, with plans to delever post-Penelope payment.